ArticleScientific reports2025
Deep learning-based artificial intelligence models predict survival in patients with oral cavity squamous cell carcinoma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Traditional survival predictions for oral squamous cell carcinoma (OSCC) rely on TNM staging, which lacks individualized prognostic value. Clinical factors such as performance status, age, sex, and lifestyle affect outcomes but are underrepresented in conventional models. This study applied artificial intelligence (AI) to integrate diverse factors for OSCC survival prediction. We retrospectively analyzed 1,018 OSCC patients surgically treated between 1996 and 2020. Variables included demographics, lifestyle, ASA classification, TNM stage, PET SUVmax, peri-neural and lympho-vascular invasion, extranodal extension, depth of invasion, resection margin, and treatment modalities. A deep neural network (DNN) for multi-group classification was developed and compared with regression-based DNN, Cox proportional hazards, and random survival forest models. To address class imbalance, least squares and multi-task learning were applied. Performance was assessed with concordance index and linearity testing. Death occurred in 18.1% of patients, with mean survival of 36.8 months. Recurrence occurred at 33 months. The DNN achieved an AUC of 0.922, sensitivity 0.514, specificity 0.992, and concordance index 0.888. Linearity testing confirmed strong correlation between predicted and observed outcomes. AI models integrating clinical variables provide more accurate OSCC survival predictions than conventional staging. The multi-group DNN is a promising tool for individualized prognosis and treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.